In the News

Recent Coverage of HMS in the News
July 5, 2012

Researchers at the Wyss Institute for Biologically Inspired Engineering at Harvard have developed a novel biomimetic strategy that delivers life-saving nanotherapeutics directly to obstructed blood vessels, dissolving blood clots before they cause serious damage or even death. The research was led by Wyss Director Donald Ingber, Judah Folkman Professor of Vascular Biology at HMS, and Wyss Technology Development Fellow Netanel Korin.

July 5, 2012

An interview with John Halamka, CIO for Beth Israel Deaconess Medical Center, explores his argument for why health information exchanges should use an “opt-in to disclose” policy to safeguard patient data.

July 4, 2012

Neighboring non-cancer cells may contribute to drug resistancesresist drug treatment, researchers report in Nature. Todd Golub and Levi Garraway of HMS, the Broad Institute and Dana Farber Cancer Institute; Ravid Straussman of the Broad; and Keith Flaherty of HMS and Massachusetts General Hospital are quoted.

July 4, 2012

The delirium that sometimes follows surgery may leave older heart patients with lingering problems with their mental function, including memory and attention, according to research from Hebrew SeniorLife, Beth Israel Deaconess Medical Center and Harvard Medical School.

July 3, 2012

A biotech company in Cambridge called Genocea believes it can create the first effective T-cell vaccines. Darren Higgins, HMS professor of microbiology and immunobiology, is a cofounder of Genocea.

July 3, 2012

A new health services business is looking to catch what its founder sees as an emerging third wave in the clinical application of genomics. Mark S. Boguski, HMS associate professor of pathology at the Center for Biomedical Informatics, is quoted.

July 3, 2012

Nearly two-thirds of American teenagers admit to having "anger attacks" that involve destroying property, threatening or engaging in violence, a new study found. And one in 12 has intermittent explosive disorder, characterized by chronic, uncontrollable fits of rage. Ronald Kessler, the McNeil Family Professor of Health Care Policy at HMS, is the lead author of the study.

July 2, 2012

Working with $2 million in new grants to be announced this week, the researchers for the Alzheimer’s Disease Neuroimaging Initiative will, for the first time, start mapping the DNA of 800 participants in a study attempting to find the root causes of memory loss. Robert Green, HMS lecturer on medicine at Brigham and Women’s Hospital, is coordinating the sequencing efforts.

Pages

Submit Photo Requests to HMS
To request photos from the HMS Office of Communications and External Relations, click here.

 

Tell us about your awards
Share news of your achievements with the larger HMS community.  Click here.

 

Book Reviews
If you are a faculty member who has published a book recently, click here.